Clinical Trials Logo
NCT number NCT03305692
Study type Interventional
Source Allina Health System
Contact Ryan Gage, MS
Phone 651-241-2810
Email Ryan.Gage@allina.com
Status Not yet recruiting
Phase N/A
Start date October 2017
Completion date September 2019

Clinical Trial Summary

Cardiac resynchronization therapy (CRT) has been a valuable intervention for patients with systolic heart failure for over 15 years. Despite years of research, there is a still a 25-40% non-responder rate depending on the outcomes measured. CRT optimization is a term used to describe the act of individualizing the therapy (CRT programming) for an individual patient. This is not often performed, but when it is, echocardiography is utilized. Recent work of body surface mapping using a novel system called the ECG Belt has shown a relationship between measures of electrical dyssynchrony and acute and chronic heart pumping function. This study will compare outcomes of patients randomized to either echocardiographic or ECG Belt optimization of CRT devices.


Clinical Trial Description

This is a prospective randomized study designed to determine whether cardiac resynchronization therapy (CRT) device programming guided by the ECG Belt (Medtronic, PLC) improves echocardiographic and functional outcomes in heart failure (HF) patients. The population will include patients treated with CRT for standard indications (not implanted for the sole purposes of this study). The study will focus enrollment on patients who do not have baseline characteristics predicting the best CRT response. Therefore the study will not enroll patients having non-ischemic HF etiology, left bundle branch (LBBB) morphology, and QRSd > 150 ms or those previously RV paced.


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Not yet recruiting NCT03220659 - Optimising Pacemaker Therapy Using Multi-point Pacing (the OPT-MPP Study) N/A
Recruiting NCT02920918 - Treatment of Diabetes in Patients With Systolic Heart Failure Phase 4
Recruiting NCT02334891 - Kyoto Congestive Heart Failure Study N/A
Recruiting NCT02960685 - Telesonography for Visually Estimating Ejection Fraction N/A
Recruiting NCT02973594 - Pulse Reduction On Beta-blocker and Ivabradine Therapy Phase 4
Recruiting NCT02579200 - Inspiratory Muscle Training for Breathless Patients With Chronic Obstructive Pulmonary Disease and Heart Failure Phase 4
Active, not recruiting NCT01553045 - Reasons for Variations in Health Related Quality of Life and Symptom Burden in Patients With Atrial Fibrillation N/A
Completed NCT02946476 - Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients N/A
Recruiting NCT03183011 - Cardiac Magnetic Resonance Imaging After Cardiac Resynchronization Therapy N/A
Not yet recruiting NCT03089502 - Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity N/A
Completed NCT02401126 - Effects of Dietary Nitrate Supplementation on Cardiorespiratory Control in Chronic Heart Failure Phase 4
Recruiting NCT02099903 - Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease N/A
Not yet recruiting NCT02026505 - Evaluation of Cardiotoxic Effects of Bortezomib N/A
Recruiting NCT03073356 - Ketones in Heart Failure - Effects on Cardiac Efficiency Phase 2
Recruiting NCT03079518 - Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency Phase 2
Recruiting NCT03183323 - Implementation of Telerehabilitation In Support of HOme-based Physical Exercise for Heart Failure N/A
Recruiting NCT02797340 - Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Phase 4
Completed NCT01129635 - Optimal Coronary Sinus Lead Implantation Using Intracardiac Impedography and Magnetic Resonance Imaging N/A
Recruiting NCT02862067 - SGLT2 Inhibition in Diabetes and Heart Failure N/A
Recruiting NCT03034551 - Mobile App With Patient Financial Incentives for Adherence to Heart Failure Medications & Daily Self-Weighing N/A